Aravinthan Loganathan

About

Rheumatology Research Fellow working at the Royal National Hospital of Rheumatic Diseases in Bath. I completed my FRACP (Rheumatology) in Australia in 2021. I completed my Rheumatology training in NSW, Australia, working at Campbelltown, Wollongong and Canberra Hospitals. I initially completed my Basic Physician Training at the Princess Alexandra Hospital, Brisbane.

I have also completed a Masters's in Pain Medicine and a Master's in Public Health. I am passionate about teaching and have actively sought to provide formal and informal teaching to medical students and medical registrars.

My areas of interest in rheumatology include inflammatory myositis, connective tissue disease, vasculitis, crystal and inflammatory arthritis.

Employment

• Redcliffe Hospital Rheumatology Consultant
  2024 - Present
• Pacific Rheumatology Rheumatology Consultant
  2023 - Present
• Royal National Hospital for Rheumatic Diseases Rheumatology Services
  2022 - 2023
• Canberra Hospital Rheumatology Registrar
  2021 - 2022
• Wollongong Hospital Registrar
  2020 - 2021
• Camden and Campbelltown Hospitals Registrar
  2019 - 2020

Education

• University of Sydney Master of Medicine
• Monash University Masters of Public Health

Projects & Funding

• Ken Muirden Overseas Travelling Fellowship Arthritis Australia

Publications (12)

• Pulmonary hypertension in anti-synthetase syndrome: prevalence, comparative risk across autoimmune diseases and impact on survival
  Rheumatology 2026 DOI: 10.1093/rheumatology/keag543
  +Save
• Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project
  Sara Faghihi‐Kashani, Akira Yoshida, F. Bozán +53 more
  Arthritis & Rheumatology 2025 DOI: 10.1002/art.43038
  +Save
• Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort
  Aravinthan Loganathan, Latika Gupta, Alex Rudge +8 more
  Rheumatology 2024 DOI: 10.1093/rheumatology/keae167
  +Save
• Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank
  Clinical and Experimental Rheumatology 2024 DOI: 10.55563/clinexprheumatol/s14zq8
  +Save
• AB0815 CLINICAL PHENOTYPE AND ANTIBODY CORRELATIONS USING IMMUNOPRECIPITATION IN INDIAN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES FROM THE MYOCITE COHORT
  Scientific Abstracts 2023 DOI: 10.1136/annrheumdis-2023-eular.2218
  +Save
• P154 Real-world audit of patients with idiopathic inflammatory myositis-related interstitial lung disease in a European population
  Rheumatology 2023 DOI: 10.1093/rheumatology/kead104.195
  +Save
• P40 DETECTION OF ANTI-ZO AND OTHER RARE ANTI-SYNTHETASE SYNDROME AUTOANTIBODIES ON RESEARCH LINEBLOT IMMUNOASSAYS
  Clinical and Experimental Rheumatology 2022 DOI: 10.55563/clinexprheumatol/zka1xq
  +Save
• The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population
  Frontiers in Immunology 2022 DOI: 10.3389/fimmu.2022.975939
  +Save
• Representation Rate and Management of Gout for Patients Discharged From Emergency Departments in Illawarra Shoalhaven Local Health District
  Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2022 DOI: 10.1177/11795441221097351
  +Save
• Systematic review and meta‐analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis
  International Journal of Rheumatic Diseases 2021 DOI: 10.1111/1756-185X.14147
  +Save
• Relative survival of patients with lymphoma in Queensland according to histological subtype
  The Medical Journal of Australia 2018 DOI: 10.5694/mja17.00937
  +Save
• A case of acute phosphate nephropathy
  Medical Journal of Australia 2016 DOI: 10.5694/mja15.01084
  +Save